Recorded Chinese product: 二羟丙茶碱注射液二羟丙茶碱注射液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 石药集团欧意药业有限公司Chinese legal name: 石药集团欧意药业有限公司
主要成分Active Ingredients
- 二羟丙茶碱Erqiang Bingcha Jian
药物知识说明
二羟丙茶碱是一种在国家药监局注册认定的药品。该药品含有二羟丙茶碱-8cdab2a1等成分。
该药品关联的活性成分包括：二羟丙茶碱Erqiang Bingcha Jian。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：石药集团欧意药业有限公司Chinese legal name: 石药集团欧意药业有限公司。
您可以探索含有相同成分的其他药品：二羟丙茶碱-8cdab2a1成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 二羟丙茶碱注射液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 二羟丙茶碱Erqiang Bingcha Jian.
Manufacturers recorded for this product: 石药集团欧意药业有限公司Chinese legal name: 石药集团欧意药业有限公司.
Explore other medicines containing the same ingredient: 二羟丙茶碱 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 二羟丙茶碱注射液Recorded Chinese product: 二羟丙茶碱注射液
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 2ml:0.25g2 mL:0.25 g
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 石药集团欧意药业有限公司Chinese legal name: 石药集团欧意药业有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H13022765
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H13022765
Manufacturer
Chinese legal name: 石药集团欧意药业有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
Protect from light and keep tightly closed.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H13022765
生产企业
石药集团欧意药业有限公司(国产)
适应症
1.适用于支气管哮喘、喘息型支气管炎、阻塞性肺气肿等缓解喘息症状。|2.也用于心源性肺水肿引起的哮喘。|3.尤适用于不能耐受茶碱的哮喘病例。
用法用量
静脉滴注，一次0.25-0.75g（1-3支），以5%或10%葡萄糖注射液稀释。
不良反应
1.类似茶碱，剂量过大时可出现恶心、呕吐、易激动、失眠、心动过速、心律失常，可发生发热、脱水、惊厥等症状。|2.严重的甚至呼吸、心跳骤停。
禁忌
对本品过敏的患者，活动性消化性溃疡和未经控制的惊厥性疾病患者禁用。
注意事项
1.哮喘急性严重发作患者不首选本品。|2.茶碱类药物可致心律失常和（或）使原有的心律失常恶化；若患者心率过速和（或）心律的任何异常改变均应密切注意。|3.高血压或者消化道溃疡病史的患者慎用本品。|4.大剂量可致中枢兴奋，预服镇静药可防止。
贮藏
遮光，密闭保存。
规格
2ml:0.25g
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.